| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |